DIVI'S LABORATORIES LTD. - Update on US-FDA inspection of Unit-II at Visakhapatnam
09 Jan 2017
Divis Laboratories Ltd has informed BSE that the company has already filed its detailed response to the Form 483 observations of the US-FDA within the time permitted.
Source:
BSE India